Table 3.
Comparison of Blatchford and Rockall risk scoring systems
| Risk factor | Blatchford score | Initial Rockall score | ||
| Parameter | Score | Parameter | Score | |
| Age (yr) | - | 60-79 | 1 | |
| ≥ 80 | 2 | |||
| Systolic blood pressure (SBP) (mmHg) | 100-109 | 1 | < 100 | 2 |
| 90-99 | 2 | |||
| < 90 | 3 | |||
| Heart rate (bpm) | > 100 | 1 | > 100 with SBP ≥ 100 | 1 |
| Clinical presentation | Melena | 1 | - | |
| Syncope | 2 | |||
| Comorbidity | Hepatic disease | 2 | CHF, IHD, major comorbidity | 2 |
| Cardiac failure | 2 | Renal or liver failure, or disseminated cancer | 3 | |
| Blood urea, mg/dL (mmol/L) | 18.2-22.3 (6.5-7.9) | 2 | - | |
| 22.4-27.9 (8-9.9) | 3 | |||
| 28-69.9 (10-24.9) | 4 | |||
| ≥ 70 (≥ 25) | 6 | |||
| Hemoglobin, g/dL (mmol/L) | F: 10-11.9 (6.2-7.4) | 1 | - | |
| M: 12-12.9 (7.5-8) | ||||
| M: 10-11.9 (6.2-7.4) | 3 | |||
| F/M: < 10 (< 6.2) | 6 | |||
| Complete Rockall score | ||||
| Endoscopic diagnosis | - | Non-malignant, non-Mallory-Weis diagnosis | 1 | |
| Upper GI tract malignancy | 2 | |||
| Evidence of bleeding | - | Blood, adherent clot, active bleeding | 2 | |
M: Male; F: Female; CHF: Congestive heart failure; IHD: Ischemic heart disease.